Amneal Pharmaceuticals Inc (AMRX)
6.76
+0.55
(+8.86%)
USD |
NASDAQ |
May 03, 16:00
6.765
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals Market Cap: 2.075B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.075B |
| May 02, 2024 | 1.907B |
| May 01, 2024 | 1.879B |
| April 30, 2024 | 1.857B |
| April 29, 2024 | 1.824B |
| April 26, 2024 | 1.802B |
| April 25, 2024 | 1.811B |
| April 24, 2024 | 1.857B |
| April 23, 2024 | 1.658B |
| April 22, 2024 | 1.649B |
| April 19, 2024 | 1.664B |
| April 18, 2024 | 1.646B |
| April 17, 2024 | 1.676B |
| April 16, 2024 | 1.673B |
| April 15, 2024 | 1.701B |
| April 12, 2024 | 1.695B |
| April 11, 2024 | 1.747B |
| April 10, 2024 | 1.750B |
| April 09, 2024 | 1.759B |
| April 08, 2024 | 1.842B |
| April 05, 2024 | 1.879B |
| April 04, 2024 | 1.830B |
| April 03, 2024 | 1.848B |
| April 02, 2024 | 1.784B |
| April 01, 2024 | 1.857B |
| Date | Value |
|---|---|
| March 28, 2024 | 1.860B |
| March 27, 2024 | 1.879B |
| March 26, 2024 | 1.796B |
| March 25, 2024 | 1.814B |
| March 22, 2024 | 1.864B |
| March 21, 2024 | 1.931B |
| March 20, 2024 | 1.867B |
| March 19, 2024 | 1.946B |
| March 18, 2024 | 1.814B |
| March 15, 2024 | 1.689B |
| March 14, 2024 | 1.655B |
| March 13, 2024 | 1.658B |
| March 12, 2024 | 1.630B |
| March 11, 2024 | 1.652B |
| March 08, 2024 | 1.655B |
| March 07, 2024 | 1.630B |
| March 06, 2024 | 1.630B |
| March 05, 2024 | 1.639B |
| March 04, 2024 | 1.658B |
| March 01, 2024 | 1.679B |
| February 29, 2024 | 1.695B |
| February 28, 2024 | 1.692B |
| February 27, 2024 | 1.750B |
| February 26, 2024 | 1.784B |
| February 23, 2024 | 1.778B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
194.71M
Minimum
Mar 28 2023
2.075B
Maximum
May 03 2024
696.92M
Average
631.85M
Median
Nov 17 2020
Market Cap Benchmarks
| Fate Therapeutics Inc | 402.90M |
| Ocular Therapeutix Inc | 917.03M |
| Editas Medicine Inc | 463.88M |
| AnaptysBio Inc | 711.36M |
| AEON Biopharma Inc | 36.43M |
Market Cap Related Metrics
| PS Ratio | 0.5021 |
| Price to Book Value | 104.92 |
| Price to Free Cash Flow | 4.348 |
| Price | 6.76 |
| Earnings Yield | -7.25% |
| Operating PE Ratio | 5.359 |